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The African swine fever virus (ASFV) open reading frame A179L, which is similar to the human proto-oncogene bcl-2,
has been cloned and expressed in vaccinia virus under control of the pE/L synthetic early/late promoter. The A179L gene
product prevented cell death in HeLa and BSC-40 cells doubly infected with another recombinant vaccinia virus expressing
the interferon-induced double-stranded RNA-activated protein kinase (p68 kinase), which activates a rapid cell death charac-
teristic of apoptosis. This finding suggests that the A179L gene has a function similar to that of bcl-2 in preventing apoptosis
and may play an important role during productive ASFV infection. q 1996 Academic Press, Inc.
is involved in the suppression of apoptosis in ASFV-in-African swine fever virus (ASFV) is a large icosahedral
fected cells.DNA virus containing about 150 open reading frames (1),
DNA amplification of the A179L gene from the Spanishwhich shares many structural and biochemical proper-
isolate E70 was carried out by PCR using AmpliTaq DNAties with poxviruses. ASFV infects different species of
polymerase (Perkin–Elmer Cetus) with the followingsuids and soft ticks of the Ornithodoros genus (2). This
primers: (i) 5*-AAATATAGGGATCCGCTATGGAGGG (5*virus produces the African swine fever disease, which
primer), and (ii) 5*-CCGCGTGGATCCTATATCAAATTGCoccurs in several clinical forms ranging from highly lethal
(3* primer). Both primers contain the recognition se-to subclinical infections. Long-term ASFV persistent in-
quence for the BamHI restriction enzyme. The PCR prod-fection has been described in chronically infected pigs
uct was digested with BamHI and cloned in the plasmid(3–5). The nature of the virus–cell interactions during
pRB21 (10). The cloned gene was sequenced by the di-persistent ASFV infection is unknown. ASFV infects a
deoxynucleotide chain terminator method using specificvariety of cells of the mononuclear phagocytic system
primers to check possible sequence changes introduced(6), producing a characteristic apoptotic cell death (7).
by PCR amplification of the gene. Recombinant vacciniaApoptosis induction in vitro was observed only late after
viruses expressing the A179L gene were obtained byASFV infection (7), suggesting the existence of a gene(s),
homologous recombination with a defective vaccinia vi-which, in preventing programmed cell death, warranted
rus of protein p37 in CV-1 cells. Selection of recombinanta productive infection. An ASFV gene, LMW5-HL (A179L
vaccinia viruses was carried out on the basis of plaquein Ba71V virus), which is a homologue to bcl-2/bax, has
formation as described (10). Finally, the recombinant vac-been described (8). This gene encodes a protein of 18
cinia virus (vvA179L) was obtained after three rounds ofkDa that is synthesized in infected cells at both early
plaque purification. Additionally, a control recombinantand late times postinfection (8).
vaccinia virus was constructed by the same methodologyThe similarity of the A179L gene to bcl-2 has pointed
with the A179L gene introduced into the virus in theout its possible role during productive or persistent viral
opposite orientation (antisense; vvA179L-AS). The anti-infection. However, the function of the A179L gene has
sense recombinant was generated to analyze if overex-not been yet demonstrated. Here we describe the cloning
pression of the ASFV bcl-2 homologue exerted any effectand expression of the A179L gene in a vaccinia system
on vv replication, or as it occurred, if it was a reliableand the inhibition of p68 kinase-induced apoptosis (9) by
system for studying apoptosis induction and prevention.the recombinant vaccinia virus, suggesting that this gene
Expression of the A179L open reading frame by
vvA179L virus was assayed in monkey kidney cells (BSC-
1) at different times postinfection (m.o.i. 1). The gene1 To whom correspondence and reprint requests should be ad-
dressed. product was detected from 4 hr postinfection by immuno-
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FIG. 1. Characterization of the A179L gene expression by the recombinant vaccinia virus vvA179L. (A) Immunoprecipitation of radiolabeled (100
mCi/ml) BSC-1 cell extracts at different times after infection with the recombinant vvA179L virus (m.o.i. 1), using a monospecific antiserum against
the A179L gene product. (B) Comparative growth curve of the recombinant viruses vvA179L (h) and vvA179L-AS (antisense, j) in BSC-1 cells (m.o.i.
1). Results are expressed as the mean of two independent experiments.
precipitation of cell extracts with a monospecific antise- bly due to overexpression of the p68 kinase by the recom-
binant virus. Previous studies have demonstrated thatrum generated against the Escherichia coli-expressed
protein, and generously provided by Dr. D. L. Rock (Plum a vaccinia recombinant expressing p68 kinase triggers
inhibition of virus protein synthesis (11) and induction ofIsland Animal Disease Center, ARS, USDA, New York).
The 18-kDa protein was expressed by the recombinant apoptosis (9).
Experiments of coinfection in HeLa cells (4 PFU/cell)vaccinia virus at early and late times after infection (Fig.
1A). Monospecific antiserum failed to detect any protein with WR-68K and vvA179L viruses in the presence or
absence of IPTG were carried out to analyze the levelsproduct in mock-infected cells or in cells infected with
the vaccinia virus expressing the antisense form of of apoptosis in infected cells by ELISA and DNA lad-
dering. Quantification of histone-associated DNA frag-A179L gene (Fig. 1A). Indirect immunofluorescence of
CV1 cells infected with vvA179L virus with the monospe- ments released to the cytoplasm was performed using
a cell death detection ELISA kit (Boehringer-Mann-cific antiserum revealed a perinuclear distribution of the
protein (data not shown). heim, Germany). In this method an anti-histone anti-
body is used to detect the core histones (H2A, H2B,Expression of the gene A179L did not interfere with
the growth of vaccinia virus. A comparative titration of H3, and H4) that are complexed with the mono- and
oligonucleosome DNA fragments formed in this pro-intracellular infective viruses obtained after infection
(m.o.i. 1) with vv179L and vv179L-AS showed similar virus cess. Infected cells (8 1 102) were incubated in lysis
buffer, and after centrifugation, the cytoplasmic frac-yields in both cases (Fig. 1B).
To analyze the possible function of the A179L ASFV tion was used for ELISA as previously described (7).
Briefly, microtiter plates were coated with anti-histonegene, we evaluated its ability to prevent apoptosis medi-
ated by the double-stranded RNA-activated protein ki- monoclonal antibody and incubated with 100 ml of each
sample. The reaction was revealed with a peroxidasenase (p68 kinase) (9). The strong apoptosis induced by
the p68 kinase provides a suitable system for testing the conjugated antibody (anti-DNA-POD). Finally, ABTS
(Sigma) substrate solution was added, and optical den-antiapoptotic effect of different genes. With this aim we
used a vaccinia virus recombinant that expresses a func- sity was measured at 405 nm.
The results obtained after this analysis indicated thattional p68 kinase (WR-68K) under the control of LacI re-
pressor/operator controlling elements. In the presence the ASFV gene A179L prevented the apoptosis induced
by expression of p68 kinase (Fig. 2A). While HeLa cellsof the inducer isopropyl-b-D-thiogalactoside (IPTG) there
is autophosphorylation of p68 kinase (11) and subse- infected with WR-68K virus in the presence of IPTG
yielded high ELISA values at 24 hr postinfection, simulta-quent strong apoptosis induction (9).
In this context, the protein kinase inhibitors E3L/K3L neous expression of the A179L gene product by coinfec-
tion with vvA179L virus produced a clear inhibition of theof vaccinia virus are not able to block p68 kinase, proba-
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FIG. 2. Prevention of apoptosis by the A179L gene. (A) Amount of cytoplasmic, low-molecular-weight histone-associated DNA fragments in
apoptotic cells determined by a specific ELISA in HeLa cells mock-infected or infected with different recombinant vaccinia viruses, in the presence
or absence of IPTG. Absorbance values were obtained by averaging the two values shown for A405 and subtracting a background value of 0.039.
(B) DNA fragmentation produced in BSC-40 cells after infection with different combinations of viruses, in the presence or absence of IPTG, and
analyzed on a 1.6% agarose gel containing 0.1 mg/ml of ethidium bromide.
p68-induced apoptosis. Infection with vvA179L or WR- manner similar to that in cells infected with vT7/PR5
virus alone (Fig. 2B). This finding suggests the existence68K viruses in the absence of IPTG did not show detect-
able apoptosis by this methodology. of a different mechanism of apoptosis induction by PRRS
virus which is not inhibited by the bcl-2 homologue fromInternucleosomal DNA fragmentation was also ana-
lyzed by gel electrophoresis. Low-molecular-weight DNA ASFV.
The above results substantiate a very recent report inwas isolated from 106 BSC-40 cells infected with WR-68K
virus or coinfected with the recombinant virus vvA179L, which this ASFV gene reduced cell death rate in the
interleukin 3 (IL-3) dependent mammalian lymphoid cellin the presence or absence of IPTG, and then analyzed
by agarose gel electrophoresis. At 24 hr postinfection, a line, as assessed by Trypan blue dye exclusion after IL-
3 removal (13). In this study it has been clearly demon-DNA ladder indicative of apoptosis was observed only
when cells were infected solely with WR-68K virus in the strated that the ASFV gene A179L, in a manner similar
to human proto-oncogene bcl-2 and the Epstein–Barrpresence of IPTG, in which the expression of p68 kinase
was detected by Western blotting (data not shown). How- virus gene BHRF1 (8), inhibits the apoptosis produced
by p68 kinase. This indicates that gene A179L is func-ever, DNA a ladder was not observed when cells were
simultaneously infected with the recombinant virus tional and may be involved in apoptosis regulation during
ASFV infection. This feature may be of a great importancevvA179L, expressing the bcl-2 homologue ASFV gene.
Expression of the ASFV protein was also detectable by in the establishment of a persistent infection or in pre-
venting early apoptotic cell death in virus-infected cells,Western blotting in extracts from cells presenting inhibi-
tion of DNA fragmentation (data not shown). allowing productive viral replication.
The human bcl-2 gene has been implicated in the de-Similar results to those obtained with the A179L gene
have been observed with human bcl-2 in the same sys- velopment of follicular lymphoma in humans (14, 15), act-
ing as an apoptotic cell death suppressor (16, 17). More-tem. Bcl-2 expressed from a vaccinia virus recombinant
blocked p68-induced apoptosis (S. B. Lee, D. Rodriguez, over, characteristic cell accumulation with lymphoid hy-
perplasia has been observed in persistently infected pigsJ. R. Rodriguez, and M. Esteban, unpublished results).
Interestingly, programmed cell death mediated by the with attenuated ASFV viruses (F. Ramiro-Iba´n˜ez, A. Or-
tega, F. Ruiz-Gonzalvo, J. M. Escribano, and C. Alonso,protein encoded by open reading frame 5 from the por-
cine reproductive and respiratory syndrome (PRRS) virus, unpublished results). Experiments to elucidate the role
of A179L gene in the pathogenesis of ASFV infection arewhich has been shown to be a potent apoptosis inducer
acting upstream of bcl-2 (12), was not inhibited by the in progress. Finally, attempts to inactivate this gene from
ASFV were uniformly unsuccessful, suggesting that theA179L gene. In BSC-40 cells simultaneously infected with
vT7/PR5 virus, expressing the PRRS virus gene, and A179L gene is essential for virus viability (A. Brun, C.
Alonso, and J. M. Escribano, unpublished results).vvA179L virus, DNA fragmentation was observed, in a
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